Biovie Inc
(BIVI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,023 | 23,844 | 30,350 | 20,227 | 21,215 |
| Other current assets | 128 | 204 | 190 | 335 | 1,549 |
| TOTAL | $20,151 | $24,048 | $30,540 | $20,562 | $22,764 |
| Non-Current Assets | |||||
| Intangibles | 696 | 753 | 811 | 868 | 926 |
| Other Non-Current Assets | 391 | 407 | 422 | 60 | 71 |
| TOTAL | $1,087 | $1,160 | $1,233 | $929 | $996 |
| Total Assets | $21,238 | $25,208 | $31,773 | $21,490 | $23,760 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,453 | 3,587 | 4,410 | 3,608 | 2,715 |
| Other current liabilities | 1 | 4 | 21 | 130 | 1,112 |
| TOTAL | $6,838 | $9,352 | $12,481 | $13,981 | $13,212 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 2,970 |
| Other Non-Current Liabilities | 333 | 350 | 366 | 18 | 30 |
| TOTAL | $333 | $350 | $366 | $18 | $3,000 |
| Total Liabilities | $7,171 | $9,702 | $12,847 | $13,999 | $16,212 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,777 | 796 | 610 | 399 | 377 |
| Common Shares | 6 | 6 | 6 | 4 | 4 |
| Retained earnings | -338,710 | -334,233 | -329,292 | -320,338 | -311,936 |
| TOTAL | $14,067 | $15,506 | $18,926 | $7,491 | $7,548 |
| Total Liabilities And Equity | $21,238 | $25,208 | $31,773 | $21,490 | $23,760 |